CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Prodia Diagnostic Line Tbk PT is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Prodia Diagnostic Line Tbk PT
Kabupaten Bekas
Jl. Tekno 1 Blok C2 D E F
Phone: +62 2189842722p:+62 2189842722 Kabupaten Bekasi, 17530  Indonesia Ticker: PRDLPRDL
Business Summary
PT Prodia Diagnostic Line Tbk is an Indonesia-based company engaged in the manufacturing and processing of medical devices related to medical diagnosis. The Company's segments include Clinical Chemistry Product Segment, Hematology Product Segment, Instrument Product Segment, Immunology & Biomolecular Product Segment and Services Product Segment. Clinical Chemistry Products are a product segment used in clinical laboratory tests using enzyme-substrate reactions to aid disease diagnosis, monitor health conditions, and evaluate organ function. Hematology Products are a product segment used to analyze blood cells and other components in the laboratory using flowcytometry. Instrument Products are machines assembled from a number of components or parts to perform clinical chemistry and hematology tests, along with clinical chemistry and hematology products. Immunology and Biomolecular Products are a product segment used for immune system tests in the laboratory.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025-----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
3826 Laboratory analytical instruments
3841 Surgical and medical instruments and apparatus

General Information
Number of Employees: 55 (As of 12/31/2025)
Outstanding Shares: 1,742,900,000 (As of 12/31/2025)
Stock Exchange: JAK


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, July 15, 2026